• Hydrix Services recorded second consecutive quarter of revenue growth
• $2.52m in revenues, up 7% from previous quarter
• 15 clients with potential future project revenue of over $35m

Hydrix Limited (ASX: HYD) released its Appendix 4C for the quarter ended 30 September 2025, providing a market update. Hydrix Services achieved a strong sales quarter, recording its second consecutive quarter of revenue growth. The company reported $2.52m in revenues for the quarter, up 7% from the June quarter, primarily driven by growth in cardiac and medtech products, as well as some Australian defence and industrial clients. Hydrix Services added two new international clients, one in the USA and one in Europe. The company currently has 15 clients where paid work is being undertaken, providing more than $35.0m (over 80% international) in potential future project revenue over the next few years. Other group updates include Hydrix Medical progressing sales opportunities for its remote cardiac monitoring software, and Hydrix Venture company Gyder Surgical nearing first-in-human surgical cases in the USA and commencing a capital raise to support its US market expansion. The group's $0.57m operating loss showed a 25% improvement on the June 2025 quarter operating loss of $0.76m. Hydrix had $0.3m in cash on hand at 30 June, supported by a $2.5m Letter of Comfort from two major shareholders.

The Board sees several opportunities to grow the business and unlock shareholder value.